Literature DB >> 15185971

Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria.

Shigetaka Shimizu1, Mamoru Suzuki, Akio Tomoda, Sadao Arai, Haruhiko Taguchi, Tomoko Hanawa, Shigeru Kamiya.   

Abstract

We studied the anti-microbial effects of phenoxazines produced by the reaction of o-aminophenol or its derivatives with bovine hemoglobin, on seven species of mycobacteria such as Mycobacterium tuberculosis, Mycobacterium marinum, Mycobacterium intracellulare, Mycobacterium scrofulaceum, Mycobacterium fortuitum, Mycobacterium kansasii and Mycobacterium smegmatis and some bacteria such as Escherichia coli, Pseudomonas aeruginosa, Salmonella enterica serovar Typhimurium, Staphylococcus aureus, Listeria monocytogeneses. These phenoxazines, including 2-amino-4, 4alpha-dihydro-4alpha, 7-dimethyl-3H-phenoxzine-3-one (Phx-1), 3-amino-1, 4alpha-dihydro-4alpha, 8-dimethyl-2H-phenoxazine-2-one (Phx-2), and 2-aminophenoxazine-3-one (Phx-3), prevented the proliferation of four non-tuberculosis mycobacteria including M. scrofulaceum, M. kansasii, M. marinum, and M. intracellulare dose-dependently, though the inhibitory effects of these phenoxazines differed according to the species of mycobacteria. However these phenoxazines failed to prevent the proliferation of M. tuberculosis, M. fortuitum, and M. smegmatis, and the concerned bacteria other than mycobacteria. The present results may contribute to development of novel antibiotics against non-tuberculolsis mycobacteria.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15185971     DOI: 10.1620/tjem.203.47

Source DB:  PubMed          Journal:  Tohoku J Exp Med        ISSN: 0040-8727            Impact factor:   1.848


  7 in total

Review 1.  JNK signaling as a target for anticancer therapy.

Authors:  Kamal S Abdelrahman; Heba A Hassan; Salah A Abdel-Aziz; Adel A Marzouk; Atsushi Narumi; Hiroyuki Konno; Mohamed Abdel-Aziz
Journal:  Pharmacol Rep       Date:  2021-03-12       Impact factor: 3.024

2.  Production of 2-aminophenoxazin-3-one by Staphylococcus aureus causes false-positive results in β-galactosidase assays.

Authors:  Herman Tse; Elaine Chan; Ching-Wan Lam; Ka-Fai Leung; Pat Chow; Kim-Chung Lee; Kong-Hung Sze; Stanley K K Cheung; Man-Kit Tse; Pak-Leung Ho; Sze-Pui Leung; Susanna K P Lau; Patrick C Y Woo; Kwok-Yung Yuen
Journal:  J Clin Microbiol       Date:  2012-09-12       Impact factor: 5.948

3.  2-Aminophenoxazine-3-one and 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one cause cellular apoptosis by reducing higher intracellular pH in cancer cells.

Authors:  Xiao-Fang Che; Chun-Lei Zheng; Shin-Ichi Akiyama; Akio Tomoda
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2011       Impact factor: 3.493

4.  Oxazin-5-Ones as a Novel Class of Penicillin Binding Protein Inhibitors: Design, Synthesis and Structure Activity Relationship.

Authors:  Efeturi Abraham Onoabedje; Akachukwu Ibezim; Sunday Nwankwor Okafor; Ufuoma Shalom Onoabedje; Uchechukwu Chris Okoro
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

Review 5.  Pharmacological Activities of Aminophenoxazinones.

Authors:  Jesús G Zorrilla; Carlos Rial; Daniel Cabrera; José M G Molinillo; Rosa M Varela; Francisco A Macías
Journal:  Molecules       Date:  2021-06-07       Impact factor: 4.411

Review 6.  Prevention of carcinogenesis and development of gastric and colon cancers by 2-aminophenoxazine-3-one (Phx-3): direct and indirect anti-cancer activity of Phx-3.

Authors:  Akio Tomoda; Keisuke Miyazawa; Takafumi Tabuchi
Journal:  Int J Mol Sci       Date:  2013-08-28       Impact factor: 5.923

7.  Neutral metalloaminopeptidases APN and MetAP2 as newly discovered anticancer molecular targets of actinomycin D and its simple analogs.

Authors:  Ewelina Węglarz-Tomczak; Michał Talma; Mirosław Giurg; Hans V Westerhoff; Robert Janowski; Artur Mucha
Journal:  Oncotarget       Date:  2018-06-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.